Segall Bryant & Hamill’s Mesa Laboratories MLAB Stock Holding History

Segall Bryant & Hamill’s Portfolio MLAB Stock Details MLAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.8M	Sell	18,108 -66	-0.4%	-$6.64K	0.02%	468
2026 Q1	$1.61M	Sell	18,174 -29	-0.2%	-$2.5K	0.02%	440
2025 Q4	$1.43M	Sell	18,203 -84	-0.5%	-$6.39K	0.02%	474
2025 Q3	$1.23M	Hold	18,287	–	–	0.02%	484
2025 Q2	$1.72M	Sell	18,287 -1,723	-9%	-$189K	0.02%	460
2025 Q1	$2.37M	Sell	20,010 -447	-2%	-$60.9K	0.04%	404
2024 Q4	$2.7M	Sell	20,457 -13	-0.1%	-$1.6K	0.04%	404
2024 Q3	$2.66M	Sell	20,470 -6,402	-24%	-$753K	0.04%	406
2024 Q2	$2.33M	Buy	+26,872	New	+$2.81M	0.04%	361

Other funds holding MLAB

LPP

Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Segall Bryant & Hamill's MLAB Position: Q2 2026 in Review

Segall Bryant & Hamill reduced its Mesa Laboratories (MLAB) stake by 0.36% in Q2 2026, selling an estimated $6.64K and leaving 18,108 shares worth $1.8M. The position accounts for 0.02% of the portfolio, ranked #468.

Segall Bryant & Hamill first reported a position in MLAB in Q2 2024 and has held it in 9 quarters since. The position peaked at $2.7M in Q4 2024. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

Segall Bryant & Hamill held 18,108 shares of Mesa Laboratories worth $1.8M as of Q2 2026.
Segall Bryant & Hamill sold 66 Mesa Laboratories shares in Q2 2026, an estimated $6.64K.
Mesa Laboratories made up 0.02% of Segall Bryant & Hamill's portfolio in Q2 2026, its #468 holding.
Segall Bryant & Hamill first reported a position in Mesa Laboratories in Q2 2024 and has held it in 9 quarters since.
Segall Bryant & Hamill's Mesa Laboratories position peaked at $2.7M in Q4 2024.
160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.